Aytu Biopharma (AYTU) Deferred Taxes (2014)
Aytu Biopharma's (AYTU) quarterly Deferred Taxes came in at -$1.0 in Q4 2014, up 100.0% on a QoQ basis from -$23909.0 in Q3 2014.
Aytu Biopharma (AYTU) Deferred Taxes (2014) Analysis & Trends
Aytu Biopharma (AYTU) has 1 years of Deferred Taxes data on file, last reported at -$1.0 in Q4 2014.
- On a quarterly basis, Deferred Taxes changed N/A year-over-year to -$1.0 in Q4 2014; TTM through Dec 2015 was -$1.0, a N/A change from a year earlier, with the FY2015 full-year figure at -$23910.0, up 97.06% from the prior year.
- Deferred Taxes for Q4 2014 stood at -$1.0, up from -$23909.0 in the prior quarter.
- Over the last five years, Deferred Taxes for AYTU reached as high as -$1.0 in Q4 2014 and fell as low as -$23909.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1.00 |
| Sep 30, 2014 | -23,909.00 |